Skip to main content
Premium Trial:

Request an Annual Quote

LI-COR Biosciences, BD Biosciences Market Infrared System for Pathway Analysis

NEW YORK, Jan. 29-LI-COR Biosciences and BD Biosciences will jointly market an infrared antibody-based imaging system for cell signaling pathway analysis, the two companies said today.


In the cooperative effort, BD's Pharmigen division will supply antibodies designed for use with LI-COR's Odyssey Infrared Imaging System.


BD Biosciences Pharmigen has a license to LI-COR's IRDye800CW, and will commercialize antibodies conjugated to this dye.


These two products will allow researchers interested in cell signaling to analyze more than one target molecule at a time. LI-COR says that its infrared imaging system can detect and quantify as little as one picogram of protein in Western blots.


LI-COR, which makes infrared labeling systems for sequencing, genotyping, and proteomics, is based in Lincoln, Neb. BD Biosciences is a  business division of Becton, Dickinson and Company.

For further information, see the press release.

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.